AAL

RSV Vaccine Trial Data Sends Moderna Stock Surging

Call traders are chiming in at five times the intraday average

Deputy Editor
Jan 18, 2023 at 10:50 AM
facebook X logo linkedin


Moderna Inc (NASDAQ:MRNA) stock is enjoying vaccine tailwinds today, though outside the realm of Covid this time. The company announced positive results for a late-stage trial of mRNA-1345, its experimental messenger RNA vaccine for respiratory syncytial virus (RSV), and plans to submit it for regulatory approval consideration globally in the first half of this year. MRNA is up 8.4% at $206.55 at last glance.

Today's pop has Moderna stock trading at its highest level since Dec. 22. Up 66% in just the past three months, the shares are already sporting a 10% year-over-year gain. Plus, the stock's ascending 60-day moving average lingers below as support, and was a . 

Chardan Capital Markets raised its price target to $208 from $191 this morning. Of the 14 analysts in coverage, six carry a "strong buy" rating, with the remaining eight a "hold," so if more upbeat vaccine news emerges, the brokerage bunch may shift their bearish stance.

Options bulls have been targeting MRNA lately. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the security's 50-day call/put volume ratio of 1.59 ranks in the 97th percentile of its annual range. 

Today's events are reinforcing this bullish sentiment, as 51,000 calls have crossed the tape so far -- five times what's typically seen at this point -- in comparison to 20,000 puts. The January 210 call is the most popular by far, with new positions opening there. These options are attractively priced at the moment, too. MRNA's Schaeffer's Volatility Index (SVI) of 54% sits in the 10th percentile of its annual range. 

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.